Skip to content Skip to search
Solving Kids’ Cancer UK Children we help Donate
Powered by Google Translate

Google Translate uses Large Language Models (AI) to translate our content, therefore it may provide incorrect information when translated. Please check with your medical team before acting on any translated information.

Treating relapsed and refractory neuroblastoma

This recorded session from Solving Kids' Cancer UK's 2025 Neuroblastoma Parent Symposium presents an overview of the latest phase 1 and phase 2 clinical trials underway across Europe and North America. This session highlights emerging therapies, their scientific goals, and the hope they offer to children and families affected by neuroblastoma.

<

Related videos